Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Approach to the patient with prediabetesVanita R Aroda, Robert RatnerDiabetes/Metabolism Research and Reviews|April 13, 2011
The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a reviewVanita R Aroda, Robert RatnerDiabetes, Obesity & Metabolism|January 25, 2018
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trialsVanita R ArodaExpert Review of Endocrinology & Metabolism|October 9, 2018
Guiding diabetes screening and prevention: rationale, recommendations and remaining challengesVanita R Aroda, Asqual GetanehPostgraduate Medicine|September 10, 2011
Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetesVanita R Aroda, Mary Beth DeYoungDiabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Metformin and Type 2 Diabetes PreventionVanita R Aroda, Robert E RatnerCurrent Opinion in Endocrinology, Diabetes, and Obesity|December 21, 2022
Utilizing type 2 diabetes medications outside glycemic parameters - where are we headed?Natasha Prakash Malkani, Vanita R ArodaDiabetes, Obesity & Metabolism|August 5, 2022
Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessmentVanita R Aroda, Robert H EckelDrug Design, Development and Therapy|March 31, 2017
Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationaleSayf A Yassin, Vanita R ArodaPostgraduate Medicine|August 21, 2020
Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapyEugene E Wright, Vanita R ArodaPageof 16